Literature DB >> 22718712

Adhesion barrier reduces postoperative adhesions after cardiac surgery.

Yukihiro Kaneko1, Yasutaka Hirata, Ikuya Achiwa, Hiroyuki Morishita, Hajime Soto, Jotaro Kobayahsi.   

Abstract

Reoperation in cardiac surgery is associated with increased risk due to surgical adhesions. Application of a bioresorbable material could theoretically reduce adhesions and allow later development of a free dissection plane for cardiac reoperation. Twenty-one patients in whom a bioresorbable hyaluronic acid-carboxymethylcellulose adhesion barrier had been applied in a preceding surgery underwent reoperations, while 23 patients underwent reoperations during the same period without a prior adhesion barrier. Blinded observers graded the tenacity of the adhesions from surgical video recordings of the reoperations. No excessive bleeding requiring wound reexploration, mediastinal infection, or other complication attributable to the adhesion barrier occurred. Multiple regression analysis showed that shorter duration of the preceding surgery, non-use of cardiopulmonary bypass in the preceding surgery, and use of the adhesion barrier were significantly associated with less tenacious surgical adhesions. The use of a bioresorbable material in cardiac surgery reduced postoperative adhesions, facilitated reoperation, and did not promote complications. The use of adhesion barrier is recommended in planned staged procedures and those in which future reoperation is likely.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718712     DOI: 10.1177/0218492311435154

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

1.  Is Seprafilm valuable in infant cardiac redo procedures?

Authors:  Bruno Lefort; Jean-Marc El Arid; Anne-Lorraine Bouquiaux; Nathalie Soulé; Julie Chantreuil; Elsa Tavernier; Alain Chantepie; Paul Neville
Journal:  J Cardiothorac Surg       Date:  2015-03-31       Impact factor: 1.637

2.  Preventing post-surgical cardiac adhesions with a catechol-functionalized oxime hydrogel.

Authors:  Masaki Fujita; Gina M Policastro; Austin Burdick; Hillary T Lam; Jessica L Ungerleider; Rebecca L Braden; Diane Huang; Kent G Osborn; Jeffrey H Omens; Michael M Madani; Karen L Christman
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.